Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Cautions: If you are pregnant, nursing, have any health condition, or are taking any medication, consult your healthcare professional before using this product
Storage : keep tightly closed, in a dry place between 5-30C
This makes it easier to maintain consistent, sustainable weight loss when combined with proper nutrition and lifestyle habits
Component-Level Trial Findings CJC-1295 (without DAC, modified GRF 1-29) Phase 1 and Phase 2 work described: Dose-dependent GH elevation (2-10x baseline at studied doses, PMID 16352683) IGF-1 elevation of 1.5-3x baseline at 1-2 weeks Mild facial flushing post-injection in some participants No serious adverse events at studied doses CJC-1295 with DAC The DAC-modified version covalently binds to albumin, extending half-life to 5-8 days (PMID 16352683)
Med Toxicol Adverse Drug Exp 3(6):499504 Friedheim E, Graziano JH, Popovac D, Dragovic D, Kaul B (1978) Treatment of lead poisoning by 2,3-dimercaptosuccinic acid
